bioAffinity Technologies Stock (NASDAQ: BIAF) stock price, news, charts, stock research, profile.
You can purchase shares of bioAffinity Technologies (NASDAQ:BIAF) through any online brokerage.
Other companies in bioAffinity Technologies’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM) and Imunon (NASDAQ:IMNN).
bioAffinity Technologies has a consensus price target of $6.00.
The stock price for bioAffinity Technologies (NASDAQ: BIAF) is $0.9672 last updated December 23, 2024 at 7:20 PM EST.
There are no upcoming dividends for bioAffinity Technologies.
bioAffinity Technologies’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for bioAffinity Technologies.
bioAffinity Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.